People
Filter News
Found 48,367 articles
-
Shaun Thaxter, the former chief executive officer of Indivior, was sentenced in federal court Thursday, four months after pleading guilty to one misdemeanor count of sharing false information about the addictive properties of Suboxone Film, an opioid-based product.
-
BioSpace Movers & Shakers, Oct. 23
10/23/2020
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
The pharmaceutical supply chain is being pushed to its limit as it prepares to deliver COVID-19 vaccines and therapeutics to the entire world as soon as possible, while continuing to produce and deliver all the usual medications and products.
-
Study Suggests Bayer’s Finerenone Slows CKD Progression in Patients With Kidney Disease and T2D
10/23/2020
The findings from this study were presented at the virtual American Society of Nephrology’s (ASN) Kidney Week 2020 on October 23, and the full study was published in a recent online edition of the New England Journal of Medicine. -
Vapotherm Announces Appointment of Donald Spence to Board of Directors and the Resignations of Craig Reynolds and Geoff Pardo
10/23/2020
Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary high velocity therapy, which is used to treat patients of all ages suffering from respiratory distress, today announced the appointment of Donald Spence to the Company’s Board of Directors. Mr. Spence will serve as a member and chair of the Compensation Committ
-
Cyclacel Pharmaceuticals Announces Appointment of Mark Kirschbaum, M.D., as Chief Medical Officer
10/23/2020
Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announced the appointment of Mark Kirschbaum, M.D. as Senior Vice President & Chief Medical Officer (CMO). Dr. Kirschbaum is a highly experienced hematologist/oncologist with over 30 years of experience in molecular medicine, new drug development, clinical
-
SQZ Biotech Strengthens Board of Directors and Appoints New Chief Business Officer
10/23/2020
Marc Schegerin, MD and Sapna Srivastava, PhD join as new board members and Micah Zajic as Chief Business Officer
-
Mitsubishi Chemical Holdings Corporation: Notice Regarding Change in Representative Corporate Executive Officers
10/23/2020
Mitsubishi Chemical Holdings Corporation announced that, at the meeting of its Board of Directors held , it resolved change of representative corporate executive officers as outlined below.
-
Moderna Fully Enrolls 30,000-Person COVID-19 Vaccine Trial, Boosts Minority Participation
10/22/2020
Moderna has fully enrolled its late-stage coronavirus disease 2019 (COVID-19) vaccine trial by hitting its target of 30,000 participants. More than one-third of this cohort includes minority participants. -
October is Breast Cancer Awareness month, and Daiichi Sankyo is aiming to raise awareness about one of the most common forms of cancer across the globe.
-
It’s a day of firsts, with the launch of two new Cambridge, Mass.-based life sciences companies.
-
After reviewing its mid-pandemic performance, it became clear that its greatest challenge is around the handling of data, according to Amy P. Abernethy, M.D., Ph.D., principal deputy commissioner, FDA, speaking at the recent Demy-Colton Virtual Salon, the “Fusion of Technologies.”
-
Oculis appoints David Jacobs, M.D. as Chief Development Officer adding complementary drug development and regulatory expertise
10/22/2020
Oculis S.A., a biopharmaceutical company focused on developing transformative topical ophthalmic treatments to improve the sight and lives of patients, announces the appointment of David Jacobs, M.D., as Chief Development Officer.
-
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Senior Corporate Executive Shelley Broader to its Board of Directors
10/22/2020
Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced the appointment of Shelley Broader to the Board of Directors.
-
Senior-Level Health and Technology Communications Leader Joins Health Catalyst
10/22/2020
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, announced today the appointment of Amanda Hundt to the newly created position of Vice President of Corporate Communications.
-
Soliton Appoints Niquette Hunt to Board of Directors
10/22/2020
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Niquette Hunt to its Board of Directors. Ms. Hunt currently serves as President and CEO of Candesant Biomedical.
-
Anthony Welters Joins Gilead Sciences’ Board of Directors
10/22/2020
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Anthony Welters has been appointed to the company’s Board of Directors.
-
Enzolytics, Inc. Announces Appointment of Charles Cotropia as CEO of ENZC and Harry Zhabilov as Its CSO
10/22/2020
Enzolytics, Inc. (OTC PINK:ENZC) announced the appointment, by the Board of Directors of the Company, on October 20 of Charles Cotropia to the position of CEO of Enzolytics.
-
Edgewise Therapeutics Appoints Behrad Derakhshan as Chief Business Officer
10/22/2020
Edgewise Therapeutics, a clinical-stage biopharmaceutical company developing small molecule therapies for musculoskeletal diseases, today announced the appointment of Behrad Derakhshan, Ph.D., to the newly created position of Chief Business Officer
-
Noveome Biotherapeutics, Inc. Announces New Appointments to its Board of Directors
10/22/2020
Noveome Biotherapeutics, Inc ., a clinical stage biopharmaceutical company focused on developing next-generation biologics for the restoration of cellular integrity of damaged tissues, has appointed M. Michelle Berrey, M.D., M.P.H. and Annamaria T. Kausz, M.D., M.S. as members of the company’s Board of Directors. “We are delighted to welcome Drs. Berrey and Kausz to our Board of Directors. Each brings a wealth of e